What is the recommended management for varicella infection?

Management of Varicella (Chickenpox) Infection

For immunocompetent children and adults with uncomplicated varicella, supportive care with hygiene measures is the primary approach, while oral acyclovir is recommended for adolescents >12 years and high-risk groups; intravenous acyclovir is reserved for immunocompromised patients, complicated disease, or neonatal varicella. 1, 2

Risk Stratification and Treatment Indications

Immunocompetent Patients

Oral acyclovir treatment (800 mg five times daily for 7-10 days) is recommended for:

• Adolescents and adults >12 years of age 2
• Children with chronic cutaneous or pulmonary disorders 2
• Children receiving long-term salicylate therapy 2
• Children with atopic dermatitis 2
• Patients >50 years of age 2

The rationale is that adults and adolescents experience higher complication rates—adults are 13 times more likely to require hospitalization than children aged 5-9 years 1. Treatment must be initiated within 24 hours of rash onset for optimal efficacy 2, 3.

For otherwise healthy children <12 years with uncomplicated varicella, supportive care alone is appropriate 2, 4. The disease is typically self-limited in this population, with complications occurring in only 11-13% of cases 1.

Immunocompromised Patients

Intravenous acyclovir (10 mg/kg every 8 hours) is mandatory for:

• Patients with immune deficiencies (HIV, cancer, organ transplant recipients) 2, 4
• Patients on chronic immunosuppressive therapy 2, 4
• Neonates with varicella 2, 4
• Complicated varicella (pneumonia, encephalitis, hepatitis, disseminated disease) 2, 4

Without adequate antiviral therapy, immunocompromised patients may develop chronic ulcerations with persistent viral replication and face mortality rates of 7-17% 5. Treatment should continue for at least 7-10 days and until all lesions have completely scabbed 5.

Supportive Care Measures

Hygiene is the cornerstone of uncomplicated varicella management:

• Daily bathing with mild soap to prevent secondary bacterial infection 4
• Astringent soaks (e.g., aluminum acetate solution) to reduce pruritus 4
• Keep fingernails short and clean to minimize scratching and bacterial superinfection 4
• Isolation in a well-ventilated room until all lesions have crusted 4
• Light, non-restrictive clothing and frequent linen changes 4

Avoid aspirin in children and adolescents due to the association with Reye syndrome, which was common before this practice was discontinued in the 1980s 1. Use acetaminophen for fever control instead 4.

Special Populations

Pregnant Women

Varicella in pregnancy requires immediate intervention:

• Administer varicella-zoster immune globulin (VZIG) within 96 hours of exposure for non-immune pregnant women 1, 6
• For pregnant women who develop varicella pneumonia or other serious complications, initiate intravenous acyclovir immediately 5, 6
• Maternal varicella in the first or second trimester carries a 2-3% risk of congenital varicella syndrome 6
• Maternal infection 5 days before to 2 days after delivery poses the highest risk for severe neonatal varicella (mortality up to 30% without treatment) 1, 6

Neonates

For neonates exposed to maternal varicella within 7 days of delivery:

• Administer VZIG immediately after birth 1
• Despite VZIG, 62% of exposed neonates still develop varicella, but complications and mortality are substantially reduced 1
• If varicella develops despite VZIG, initiate intravenous acyclovir 10 mg/kg every 8 hours 2

Post-Exposure Prophylaxis

Varicella-Zoster Immune Globulin (VZIG)

VZIG (VariZIG) is indicated within 96 hours of exposure for:

• Immunocompromised patients without evidence of immunity 1
• Pregnant women without evidence of immunity 1
• Neonates whose mothers developed varicella 5 days before to 2 days after delivery 1
• Premature infants <28 weeks gestation or <1,000 g 7
• Hospitalized premature infants whose mothers lack evidence of immunity 1

Dosing: 125 units per 10 kg body weight, up to a maximum of 625 units (five vials), administered intramuscularly 1. VZIG may extend the incubation period from 10-21 days to >28 days, which must be considered for isolation planning 1.

Varicella Vaccination for Post-Exposure Prophylaxis

For healthy, non-immune individuals exposed to varicella:

• Administer varicella vaccine within 3 days of exposure for >90% efficacy in preventing disease 7
• Vaccination within 5 days of exposure is 70% effective in preventing disease and 100% effective in modifying severity 7
• This approach is preferred over VZIG for immunocompetent individuals, as it provides long-term immunity 7, 3

Household contacts face the highest transmission risk—approximately 85% (range 65-100%) of susceptible household contacts develop varicella after exposure 1, 7.

Monitoring and Complications

Watch for complications requiring escalation of care:

• Bacterial superinfection (most common): Group A streptococcal cellulitis, abscess formation 1
• Varicella pneumonia: Occurs in 1 in 400 adults; presents with dyspnea, cough, chest pain 3-5 days after rash onset 1, 6
• Neurological complications: Cerebellar ataxia (most common in children), encephalitis, Guillain-Barré syndrome 1
• Hepatitis: Elevated transaminases, right upper quadrant pain 1
• Hemorrhagic varicella: Indicates severe disease, often in immunocompromised hosts 1

Any of these complications mandate immediate hospitalization and intravenous acyclovir therapy 2, 4.

Infection Control

Patients with varicella are contagious from 1-2 days before rash onset until all lesions have crusted (typically 5-7 days after rash onset) 1, 3. Implement airborne and contact precautions in healthcare settings 5. Exclude infected children from school or daycare until all lesions have crusted 1.

Common Pitfalls

• Do not use topical acyclovir—it is substantially less effective than systemic therapy and is not recommended 5
• Do not prescribe antibiotics prophylactically—17% of providers inappropriately prescribe antibiotics for uncomplicated varicella 8
• Do not delay treatment in high-risk patients—acyclovir must be started within 24 hours of rash onset for maximum benefit 2, 3
• Do not confuse varicella dosing with herpes zoster dosing—varicella requires 800 mg five times daily, not the lower doses used for genital herpes 5
• Do not use VZIG for healthy adults—vaccination is more appropriate and provides lasting immunity 7

Prevention

Routine varicella vaccination has dramatically reduced disease burden:

• Two-dose series (first dose at 12-15 months, second at 4-6 years) provides 98% protection against varicella 3
• Since vaccine introduction in 1995, an estimated 3.5 million cases, 9,000 hospitalizations, and 100 deaths are prevented annually in the United States 8
• Vaccine is contraindicated in pregnancy and severe immunocompromise 3